全文获取类型
收费全文 | 2321篇 |
免费 | 190篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 66篇 |
妇产科学 | 61篇 |
基础医学 | 287篇 |
口腔科学 | 46篇 |
临床医学 | 331篇 |
内科学 | 418篇 |
皮肤病学 | 51篇 |
神经病学 | 139篇 |
特种医学 | 216篇 |
外科学 | 158篇 |
综合类 | 67篇 |
一般理论 | 1篇 |
预防医学 | 264篇 |
眼科学 | 61篇 |
药学 | 183篇 |
中国医学 | 4篇 |
肿瘤学 | 114篇 |
出版年
2021年 | 30篇 |
2020年 | 22篇 |
2019年 | 33篇 |
2018年 | 40篇 |
2017年 | 34篇 |
2016年 | 32篇 |
2015年 | 26篇 |
2014年 | 60篇 |
2013年 | 90篇 |
2012年 | 98篇 |
2011年 | 82篇 |
2010年 | 52篇 |
2009年 | 46篇 |
2008年 | 82篇 |
2007年 | 103篇 |
2006年 | 102篇 |
2005年 | 80篇 |
2004年 | 99篇 |
2003年 | 58篇 |
2002年 | 81篇 |
2001年 | 82篇 |
2000年 | 67篇 |
1999年 | 64篇 |
1998年 | 40篇 |
1997年 | 37篇 |
1996年 | 38篇 |
1995年 | 28篇 |
1994年 | 36篇 |
1993年 | 28篇 |
1992年 | 49篇 |
1991年 | 49篇 |
1990年 | 52篇 |
1989年 | 63篇 |
1988年 | 46篇 |
1987年 | 65篇 |
1986年 | 61篇 |
1985年 | 83篇 |
1984年 | 49篇 |
1983年 | 36篇 |
1982年 | 26篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 21篇 |
1978年 | 20篇 |
1977年 | 15篇 |
1976年 | 19篇 |
1975年 | 15篇 |
1974年 | 22篇 |
1973年 | 22篇 |
1967年 | 15篇 |
排序方式: 共有2525条查询结果,搜索用时 0 毫秒
61.
High‐resolution analysis of central nervous system expression patterns in zebrafish Gal4 enhancer‐trap lines 下载免费PDF全文
62.
In order to study the effect of progesterone in modulating the secretion of gonadotropins, various doses of progesterone were administered to castrated immature and mature female rats. Progesterone did not prevent the postcastration rise of FSH and LH in these animals. Various amounts of progesterone were then administered to castrated rats that were treated with a constant low dose of estradiol. In animals given doses of estradiol that were able to decrease serum FSH and LH below castrate levels, but not to prevent the post-castration rise, the effect of progesterone was dose-dependent. A very low dose of progesterone lowered serum gonadotropins, an intermediate dose brought about an increase in secretion, and high doses were suppressive. The modifying action of progesterone appears to be dependent upon the level of estrogen, the dose of progesterone, and the time of administration. 相似文献
63.
64.
Stirnadel H Lin X Ling H Song K Barter P Kesäniemi YA Mahley R McPherson R Waeber G Bersot T Cohen J Grundy S Mitchell B Mooser V Waterworth D 《Atherosclerosis》2008,197(2):868-876
Atherogenic dyslipidemia, manifest by low HDL-cholesterol and high TG levels, is an important component of ATP-III defined metabolic syndrome. Here, we dissected the phenotypic and genetic architecture of these traits by assessing their relationships with other metabolically relevant measures, including plasma adipo-cytokines, highly sensitive C-reactive protein (hsCRP) and LDL particle size, in a large family data set (n=2800) and in an independent set of dyslipidemic cases (n=716) and normolipidemic controls (n=1073). We explored the relationships among these phenotypes using variable clustering and then estimated their genetic heritabilities and cross-trait correlations. In families, four clusters explained 61% of the total variance, with one adiposity-related cluster (including hsCRP), one BP-related cluster, and two lipid-related clusters (HDL-C, TG, adiponectin and LDL particle size; apoB and non-HDL-C). A similar structure was observed in dyslipidemic cases and normolipidemic controls. The genetic correlations in the families largely paralleled the phenotype clustering results, suggesting that common genes having pleiotropic effects contributed to the correlations observed. In summary, our analyses support a model of metabolic syndrome with two major components, body fat and lipids, each with two subcomponents, and quantifies their degree of overlap with each other and with metabolic-syndrome related measures (adipokines, LDL particle size and hsCRP). 相似文献
65.
Ahmed A. Harhash Teresa L. May Chiu-Hsieh Hsu Sachin Agarwal David B. Seder Michael R. Mooney Nainesh Patel John McPherson Paul McMullan Richard Riker Eldar Soreide Karen G. Hirsch Pascal Stammet Alison Dupont Sten Rubertsson Hans Friberg Niklas Nielsen Tanveer Rab Karl B. Kern 《Journal of the American College of Cardiology》2021,77(4):360-371
BackgroundThe American College of Cardiology Interventional Council published consensus-based recommendations to help identify resuscitated cardiac arrest patients with unfavorable clinical features in whom invasive procedures are unlikely to improve survival.ObjectivesThis study sought to identify how many unfavorable features are required before prognosis is significantly worsened and which features are most impactful in predicting prognosis.MethodsUsing the INTCAR (International Cardiac Arrest Registry), the impact of each proposed “unfavorable feature” on survival to hospital discharge was individually analyzed. Logistic regression was performed to assess the association of such unfavorable features with poor outcomes.ResultsSeven unfavorable features (of 10 total) were captured in 2,508 patients successfully resuscitated after cardiac arrest (ongoing cardiopulmonary resuscitation and noncardiac etiology were exclusion criteria in our registry). Chronic kidney disease was used in lieu of end-stage renal disease. In total, 39% survived to hospital discharge. The odds ratio (OR) of survival to hospital discharge for each unfavorable feature was as follows: age >85 years OR: 0.30 (95% CI: 0.15 to 0.61), time-to-ROSC >30 min OR: 0.30 (95% CI: 0.23 to 0.39), nonshockable rhythm OR: 0.39 (95% CI: 0.29 to 0.54), no bystander cardiopulmonary resuscitation OR: 0.49 (95% CI: 0.38 to 0.64), lactate >7 mmol/l OR: 0.50 (95% CI: 0.40 to 0.63), unwitnessed arrest OR: 0.58 (95% CI: 0.44 to 0.78), pH <7.2 OR: 0.78 (95% CI: 0.63 to 0.98), and chronic kidney disease OR: 0.96 (95% CI: 0.70 to 1.33). The presence of any 3 or more unfavorable features predicted <40% survival. Presence of the 3 strongest risk factors (age >85 years, time-to-ROSC >30 min, and non-ventricular tachycardia/ventricular fibrillation) together or ≥6 unfavorable features predicted a ≤10% chance of survival to discharge.ConclusionsPatients successfully resuscitated from cardiac arrest with 6 or more unfavorable features have a poor long-term prognosis. Delaying or even forgoing invasive procedures in such patients is reasonable. 相似文献
66.
Poupon V Girard M Legendre-Guillemin V Thomas S Bourbonniere L Philie J Bright NA McPherson PS 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(1):168-173
Clathrin-coated vesicles (CCVs) are major carriers for endocytic cargo and mediate important intracellular trafficking events at the trans-Golgi network (TGN) and endosomes. Whereas clathrin heavy chain provides the structural backbone of the clathrin coat, the role of clathrin light chains (CLCs) is poorly understood. We now demonstrate that CLCs are not required for clathrin-mediated endocytosis but are critical for clathrin-mediated trafficking between the TGN and the endosomal system. Specifically, CLC knockdown (KD) causes the cation-independent mannose-6 phosphate receptor (CI-MPR) to cluster near the TGN leading to a delay in processing of the lysosomal hydrolase cathepsin D. A recently identified binding partner for CLCs is huntingtin-interacting protein 1-related (HIP1R), which is required for productive interactions of CCVs with the actin cytoskeleton. CLC KD causes mislocalization of HIP1R and overassembly of actin, which accumulates in patches around the clustered CI-MPR. A dominant-negative CLC construct that disrupts HIP1R/CLC interactions causes similar alterations in CI-MPR trafficking and actin assembly. Thus, in mammalian cells CLCs function in intracellular membrane trafficking by acting as recruitment proteins for HIP1R, enabling HIP1R to regulate actin assembly on clathrin-coated structures. 相似文献
67.
68.
Yonghoon Rim Susan T. Laing David D. McPherson Hyunggun Kim 《Annals of biomedical engineering》2014,42(1):139-148
Mitral valve (MV) repair using expanded polytetrafluoroethylene sutures is an established and preferred interventional method to resolve the complex pathophysiologic problems associated with chordal rupture. We developed a novel computational evaluation protocol to determine the effect of the artificial sutures on restoring MV function following valve repair. A virtual MV was created using three-dimensional echocardiographic data in a patient with ruptured mitral chordae tendineae (RMCT). Virtual repairs were designed by adding artificial sutures between the papillary muscles and the posterior leaflet where the native chordae were ruptured. Dynamic finite element simulations were performed to evaluate pre- and post-repair MV function. Abnormal posterior leaflet prolapse and mitral regurgitation was clearly demonstrated in the MV with ruptured chordae. Following virtual repair to reconstruct ruptured chordae, the severity of the posterior leaflet prolapse decreased and stress concentration was markedly reduced both in the leaflet tissue and the intact native chordae. Complete leaflet coaptation was restored when four or six sutures were utilized. Computational simulations provided quantitative information of functional improvement following MV repair. This novel simulation strategy may provide a powerful tool for evaluation and prediction of interventional treatment for RMCT. 相似文献
69.
Susan E. Daniels Philip Beineke Brian Rhees John A. McPherson William E. Kraus Gregory S. Thomas Steven Rosenberg 《Journal of cardiovascular translational research》2014,7(7):615-622
A gene expression score (GES) for obstructive coronary artery disease (CAD) has been validated in two multicenter studies. Receiver-operating characteristics (ROC) analysis of the GES on an expanded Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) cohort (NCT no. 00500617) with CAD defined by quantitative coronary angiography (QCA) or clinical reads yielded similar performance (area under the curve (AUC)?=?0.70, N?=?1,502) to the original validation cohort (AUC?=?0.70, N?=?526). Analysis of 138 non-Caucasian and 1,364 Caucasian patients showed very similar performance (AUCs?=?0.72 vs. 0.70). To assess analytic stability, stored samples of the original validation cohort (N?=?526) was re-tested after 5 years, and the mean score changed from 20.3 to 19.8 after 5 years (N?=?501, 95 %). To assess patient scores over time, GES was determined on samples from 173 Coronary Obstruction Detection by Molecular Personalized Gene Expression (COMPASS) study (NCT no. 01117506) patients at approximately 1 year post-enrollment. Mean scores increased slightly from 15.9 to 17.3, corresponding to a 2.5 % increase in obstructive CAD likelihood. Changes in cardiovascular medications did not show a significant change in GES. 相似文献